CSS - Spectra-Physics InSight X3 Dual Laser System

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98027Q00072. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services restricted to the Brand Name specified herein in accordance with FAR 13.106-1(b)(1)(i). The Government intends to award a firm-fixed-price purchase order resulting from this solicitation using competition among the Original Equipment Manufacturer (OEM) and its authorized distributors. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, on behalf of the National Heart, Lung, and Blood Institute (NHLBI), seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026.
(iv) The associated NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), and the small business size standard is 1,000 employees.
¿ This requirement is unrestricted.
(v) Description of Requirement: The National Heart, Lung, and Blood Institute (NHLBI), Laboratory of Advanced Microscopy and Biophotonics (LAMB), requires one (1) Brand Name Spectra-Physics (Newport Corporation / MKS Instruments) InSight® X3¿ Dual Ultrafast Laser System to integrate with an existing Thorlabs Veneto inverted multiphoton microscope for Fluorescence Lifetime Imaging Microscopy (FLIM) and Stimulated Raman Scattering (SRS) pump-probe experiments studying the effects of chemotherapeutic agents on cellular metabolism.